Advertisement

Related Videos

Amit Sanyal, MD: A Clinician’s Perspective

The Interventional Pharmacoeconomic Toolbox Panel Discussion

Clifford A. Hudis, MD: Are Cancer Drug Prices in the U.S. the Problem or the Symptom?

Sarah Yim, MD, on Clinical Development of Biosimilars: Lessons for Interventional Pharmacoeconomics

Peter Clark, MA, MD, FRCP: A Payer Perspective

Advertisement

Advertisement




Feb
10
Today In Oncology
A New Risk Model for Esophagectomy Draws on the STS National Database
Olaparib in Metastatic Breast Cancer With Germline Mutations in PALB2 or Somatic Mutations in BRCA
Ultra–Low-Dose Immunotherapy in Relapsed or Refractory Solid Tumors
ASCO and Conexiant Launch ASCO AI in Oncology
Self-Acupressure May Ease Fatigue in Ovarian Cancer Survivors
View More 
Advertisement
© 2026 HSP News Service, L.L.C.
Conexiant Oncology Logo